Clinical Trial

Observational Study in Localized Osteosarcoma

Study acronym: ISG Os2Oss
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 27, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Observational prospective trial aimed to collect the collect demographic, clinical, surgical, pathological and molecular characteristics and treatment from patients affected by localized OsteoSarcoma (OS) treated according the AIEOP/Italian Sarcoma Group (ISG) OS 2021
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2021-05-12; most recent amendment 2026-03-24.
Status change: Active, Not Recruiting → Recruiting 2023-09-12
Status change: Not Yet Recruiting → Active, Not Recruiting 2021-10-29
Trial Details
NCT Number NCT04890067
Lead Sponsor Italian Sarcoma Group
Collaborators: Associazione Italiana Ematologia Oncologia Pediatrica
Conditions Localized Osteosarcoma
Enrollment 120 participants
Start Date 2021-07-30
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-03-27